Amanote Research
Register
Sign In
Psy137 - Orphan Drug Access and Reimbursement in the Eu5: Cystic Fibrosis and Duchenne Muscular Dystrophy
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2711
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
Y. Privolnev
J. Cox
M. Breen
A. Reyes
Publisher
Elsevier BV
Related search
Direct PCR From CVS and Blood Lysates for Detection of Cystic Fibrosis and Duchenne Muscular Dystrophy Deletions
Nucleic Acids Research
Genetics
Duchenne Muscular Dystrophy
Physiotherapy
Physical Therapy
Sports Therapy
Rehabilitation
Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Methods in Molecular Biology
Genetics
Molecular Biology
Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy and Brain Function
Disability and Survival in Duchenne Muscular Dystrophy
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Recognising and Preventing Duchenne Muscular Dystrophy
Journal of Pediatric Orthopaedics
Pediatrics
Child Health
Perinatology
Orthopedics
Medicine
Sports Medicine
Bladder Dysfunction in Duchenne Muscular Dystrophy
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology